Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Molecular and Functional Characterization of Human P2X2 Receptors

Kevin J. Lynch, Edward Touma, Wende Niforatos, Karen L. Kage, Edward C. Burgard, Tim van Biesen, Elizabeth A. Kowaluk and Michael F. Jarvis
Molecular Pharmacology December 1999, 56 (6) 1171-1181; DOI: https://doi.org/10.1124/mol.56.6.1171
Kevin J. Lynch
Neurological and Urological Diseases Research, Abbott Laboratories, Abbott Park, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward Touma
Neurological and Urological Diseases Research, Abbott Laboratories, Abbott Park, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wende Niforatos
Neurological and Urological Diseases Research, Abbott Laboratories, Abbott Park, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen L. Kage
Neurological and Urological Diseases Research, Abbott Laboratories, Abbott Park, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward C. Burgard
Neurological and Urological Diseases Research, Abbott Laboratories, Abbott Park, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim van Biesen
Neurological and Urological Diseases Research, Abbott Laboratories, Abbott Park, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth A. Kowaluk
Neurological and Urological Diseases Research, Abbott Laboratories, Abbott Park, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael F. Jarvis
Neurological and Urological Diseases Research, Abbott Laboratories, Abbott Park, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

P2X receptors are a family of ATP-gated ion channels. Four cDNAs with a high degree of homology to the rat P2X2 receptor were isolated from human pituitary and pancreas RNA. Genomic sequence indicated that these cDNAs represent alternatively spliced messages. Northern analysis revealed high levels of human P2X2(hP2X2) message in the pancreas, and splice variants could be detected in a variety of tissues. Two cDNAs encoded functional ion channels when expressed in Xenopus oocytes, a receptor structurally homologous to the prototype rat P2X2 receptor (called hP2X2a) and a variant containing a deletion within its cytoplasmic C terminus (called hP2X2b). Pharmacologically, these functional human P2X2 receptors were virtually indistinguishable, with the P2X receptor agonists ATP, 2-methylthio-ATP, 2′ and 3′-O-(4-benzoylbenzoyl)-ATP, and ATP5′-O-(3-thiotriphosphate) being approximately equipotent (EC50 = 1 μM) in eliciting extracellular Ca2+ influx. The P2 receptor agonists α,β-methylene ATP, adenosine, adenosine 5′-O-(2-thiodiphosphate), and UTP were inactive at concentrations up to 100 μM. Both hP2X2a and hP2X2b receptors were sensitive to the P2 receptor antagonist pyridoxal-5-phosphate-6-azophenyl-2′,4′-disulfonic acid (IC50 = 3 μM). In contrast to the analogous rat P2X2 and P2X2b receptors, the desensitization rates of the hP2X2a and hP2X2b receptors were equivalent. Both functional forms of the human P2X2receptors formed heteromeric channels with the human P2X3receptor. These data demonstrate that the gene structure and mRNA heterogeneity of the P2X2 receptor subtype are evolutionarily conserved between rat and human, but also suggest that alternative splicing serves a function other than regulating the desensitization rate of the human receptor.

Footnotes

    • Received June 3, 1999.
    • Accepted August 20, 1999.
  • Send reprint requests to: Kevin J. Lynch, Ph.D., Abbott Laboratories, 100 Abbott Park Rd., Abbott Park, IL 60064. E-mail:Kevin.Lynch{at}abbott.com

  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 56 (6)
Molecular Pharmacology
Vol. 56, Issue 6
1 Dec 1999
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Molecular and Functional Characterization of Human P2X2 Receptors
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Molecular and Functional Characterization of Human P2X2 Receptors

Kevin J. Lynch, Edward Touma, Wende Niforatos, Karen L. Kage, Edward C. Burgard, Tim van Biesen, Elizabeth A. Kowaluk and Michael F. Jarvis
Molecular Pharmacology December 1, 1999, 56 (6) 1171-1181; DOI: https://doi.org/10.1124/mol.56.6.1171

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Molecular and Functional Characterization of Human P2X2 Receptors

Kevin J. Lynch, Edward Touma, Wende Niforatos, Karen L. Kage, Edward C. Burgard, Tim van Biesen, Elizabeth A. Kowaluk and Michael F. Jarvis
Molecular Pharmacology December 1, 1999, 56 (6) 1171-1181; DOI: https://doi.org/10.1124/mol.56.6.1171
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
  • Benzbromarone Relaxes Airway Smooth Muscle via BK Activation
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics